Retatrutide
A triple-agonist peptide investigated in clinical trials for metabolic and body-composition endpoints. One of the most-studied next-generation incretin candidates.
Read the Retatrutide research guide→In stock
✓ 100% purity-match & safe-arrival guarantee
✓ Orders placed before 2:00 PM CT on a business day ship the same day.
✓ Free shipping over $200. One discount per order.
- Great value!Make this a kitRetatrutide + 3 mL BAC water + 10 syringes + 10alcohol pads — pads free, water & syringes 25% offStarting at$102.32$110.35
- Bacteriostatic Water0.9% benzyl alcohol water for reconstitution, sold as a single vial.$13.14
- Insulin Syringes31G 0.5 mL sterile syringes, sold in packs of 10, 100, or 300.$7
- Alcohol Prep Pads70% isopropyl alcohol pads, sold in packs of 10 or 200.$3
- Best value!Metabolic Starter Kit: BeginnerThe entry metabolic bench set: Semaglutide (a GLP-1 reference compound) with Tesamorelin, plus the water to reconstitute them. 10 syringes and a 10-pack of alcohol prep pads are included free, an added bonus with every starter kit.Starting at$149$207
Molecular specification
- Molecular formula
- C221H342N46O68
- Molecular weight
- 4731.3 g/mol
- CAS number
- 2381089-83-2
- Amino acids
- 39
- Appearance
- White lyophilized powder
- Purity (HPLC)
- 99.2%
- Elimination half-life
- ≈ 6 days (144–165 h)
Mechanism & published research
Acts as an agonist at GLP-1, GIP, and glucagon receptors simultaneously; the added glucagon activity is the primary point of research interest versus dual agonists.
Studied for significant body-weight change over 48 weeks in a phase 2 program.
Triple-receptor pharmacology characterized in receptor-binding and preclinical models.
Descriptions summarize existing published research and are not claims about outcomes from use. Every citation states its study type and population.
How it compares
| Versus | Attribute | Note |
|---|---|---|
| Tirzepatide | Receptor targets | Retatrutide adds glucagon-receptor activity to the GLP-1/GIP profile. |
| Semaglutide | Mechanism | Semaglutide is GLP-1 only; retatrutide is a triple agonist. |
Retatrutide vial research model
Published study charts, concentration and supply calculations, with an interactive preparation model.
Open the full reference →Reconstitution
Concentration math only: add bacteriostatic water to the vial and the resulting concentration is shown below. This is not usage guidance.
| Vial | Bacteriostatic water | Concentration |
|---|---|---|
| 10 mg | 2 mL | 5 mg/mL |
| 20 mg | 2 mL | 10 mg/mL |
| 30 mg | 2 mL | 15 mg/mL |
| 60 mg | 2 mL | 30 mg/mL |
Storage & stability
| State | Temperature | Duration |
|---|---|---|
| Lyophilized (unopened) | -20°C | 24 months |
| Reconstituted | 2–8°C | up to 4 weeks |
Reviews
Reviews are collected post-delivery and screened to exclude any human-use or dosing-outcome claims before publication. They speak to product quality, shipping, and COA accuracy.
“99.2% on the certificate and the reconstituted solution was water-clear with no particulates.”
“The lot on the vial matched the COA in the hub and verified on the lab portal. That check is why I keep ordering.”
“The batch on the vial resolved on the verification page instantly. Consistent with what the product page listed.”
Product FAQ
What vial sizes are available?+
10 mg, 20 mg, and 30 mg lyophilized vials, each with a lot-specific COA.
How is it shipped?+
Lyophilized, with an insulated cold pack, tracked. Reconstitute on arrival or keep frozen.
Related compounds
Tirzepatide
Dual GIP / GLP-1 receptor agonist, extensively studied.
Semaglutide
GLP-1 receptor agonist with a deep clinical literature.
Cagrilintide
Long-acting amylin analog studied with incretins.
Survodutide
GLP-1 / glucagon dual receptor agonist.